Source comparison
Tesamorelin + Ipamorelin Blend Results After 1 Week: Comparison
Serum IGF-1 Levels +18–28% above baseline +40–60% above baseline +50–80% above baseline (plateau) IGF-1 rises sharply in week one, plateaus by week 12. Early increase confirms receptor engagement Visceral Adipose Tissue (VAT) Reduction 0–2% (not statistically
This comparison does not assign a generated winner or score.
- Serum IGF-1 Levels
- +18–28% above baseline
- +40–60% above baseline
- +50–80% above baseline (plateau)
- IGF-1 rises sharply in week one, plateaus by week 12. Early increase confirms receptor engagement
- Visceral Adipose Tissue (VAT) Reduction
- 0–2% (not statistically significant)
- 5–8% reduction via DEXA
- 12–18% reduction via DEXA
- Fat loss lags hormonal changes by 3–4 weeks. Week one shows zero visible reduction
- Sleep Quality (SWS Duration)
- +12–18 minutes per night
- +20–30 minutes per night
- +25–35 minutes per night (stable)
- Sleep improvements appear within 3–5 nights and plateau by week six
- Muscle Recovery Time (DOMS)
- 20–30% reduction in 48-hour soreness
- 30–40% reduction
- 35–50% reduction (stable)
- Recovery timing improves immediately as IGF-1 drives satellite cell activation
- Lean Body Mass (LBM)
- +0.2–0.5kg (fluid and glycogen, not muscle)
- +1–2kg (measurable hypertrophy)
- +2.5–4kg (sustained anabolism)
- Week one gains are glycogen and intracellular water. True hypertrophy requires 4+ weeks
- Skin Thickness (Dermal Collagen)
- No measurable change
- Subtle improvement in hydration and elasticity
- 8–12% increase in dermal thickness via ultrasound
- Collagen synthesis begins in week one but requires 6–8 weeks to manifest visibly